Offer - Urjas Oil for just ₹ 1 X
Nosodime 250 Injection is a commercial drug that is prescribed in the form of Injection. Skin Infections, Pneumonia are some of its major therapeutic uses. Nosodime 250 Injection also has some secondary and off-label uses. These are listed below.
The correct dosage of Nosodime 250 Injection depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Nosodime 250 Injection can also lead to other problems, which have been listed below. These side effects of Nosodime 250 Injection are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Nosodime 250 Injection's effect is Safe during pregnancy and Safe for lactating mothers. Further, the section on Nosodime 250 Injection related warnings talks about Nosodime 250 Injection's effects on the liver, heart and kidney.
Nosodime 250 Injection can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Nosodime 250 Injection in conditions like Kidney Disease. Other conditions have been mentioned below in the Nosodime 250 Injection contraindications section.
Drug reaction of Nosodime 250 Injection with other medicines has been reported. See below for a complete list.
In addition to these precautions, you may also note that Nosodime 250 Injection is not safe while driving, and is is not addictive in nature.
Nosodime 250 Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
Is the use of Nosodime 250 Injection safe for pregnant women?
Nosodime is safe for pregnant women.
Is the use of Nosodime 250 Injection safe during breastfeeding?
Nosodime is safe for breastfeeding women.
What is the effect of Nosodime 250 Injection on the Kidneys?
Nosodime may have mild side effects on the kidneys.
What is the effect of Nosodime 250 Injection on the Liver?
Nosodime is not harmful for the liver.
What is the effect of Nosodime 250 Injection on the Heart?
Using Nosodime does not have any harmful effects on the heart.
If you are suffering from any of the following diseases, you should not take Nosodime 250 Injection unless your doctor advises you to do so -
Is this Nosodime 250 Injection habit forming or addictive?
Forming a habit of Nosodime 250 Injection has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Nosodime 250 Injection, you should not drive or work on any heavy machine, as Nosodime 250 Injection can make you drowsy.
Is it safe?
Yes, Nosodime 250 Injection is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, the use of Nosodime 250 Injection in mental disorders is not effective.
Interaction between Food and Nosodime 250 Injection
Taking Nosodime 250 Injection with food is safe.
Interaction between Alcohol and Nosodime 250 Injection
Due to lack of research, there is no information about the side effects of taking Nosodime 250 Injection with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; FORTAZ® (ceftazidime)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-312